| Sherry H Weitzen, MD | |
|
48 Sanderson St, Greenfield, MA 01301-2778 | |
| (413) 773-2778 | |
| (413) 773-4945 |
| Full Name | Sherry H Weitzen |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | 48 Sanderson St, Greenfield, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124387055 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD2014-0638 (New Mexico) | Secondary |
| 207Q00000X | Family Medicine | 262783 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of New Mexico Hospital | Albuquerque, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of New Mexico Medical Group | 4981795267 | 1002 |
News Archive
In response to a story examining 2011's top foreign policy issues, Serra Sippel, president of the Center for Health and Gender Equity, writes in a letter to the editor, published in The Hill, that "[g]lobal health was disturbingly absent from" the story. "Global health policy is at a critical turning point right now with the impending implementation of President Obama's Global Health Initiative, which will change our fundamental approach to health programs and policy," according to Sippel.
Following the closure of several research programs for Alzheimer's disease, in early 2018 the FDA issued a release entitled "Draft Guidance for Industry: Early Alzheimer's Disease: Developing Drugs for Treatment." Encouraged by the proposed changes in the new guidance, Genervon's research team reported new findings that its drug candidate GM6 attenuates Alzheimer's disease in an early AD transgenic APP mice model.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today its participation in a $2.4 million research grant awarded to the University of Pennsylvania under the "American Recovery and Reinvestment Act of 2009". The new grant will fund research over two years in the laboratories of Daniel Rader, M.D. of the University of Pennsylvania School of Medicine, Sekar Kathiresan, M.D. of Massachusetts General Hospital (MGH) and Harvard Medical School, and Alnylam.
A team of researchers describes the presence of PDCoV strains in plasma samples of three Haitian children with acute undifferentiated febrile illness.
› Verified 6 days ago
| Entity Name | Unm Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831218627 PECOS PAC ID: 4981795267 Enrollment ID: O20070801000589 |
News Archive
In response to a story examining 2011's top foreign policy issues, Serra Sippel, president of the Center for Health and Gender Equity, writes in a letter to the editor, published in The Hill, that "[g]lobal health was disturbingly absent from" the story. "Global health policy is at a critical turning point right now with the impending implementation of President Obama's Global Health Initiative, which will change our fundamental approach to health programs and policy," according to Sippel.
Following the closure of several research programs for Alzheimer's disease, in early 2018 the FDA issued a release entitled "Draft Guidance for Industry: Early Alzheimer's Disease: Developing Drugs for Treatment." Encouraged by the proposed changes in the new guidance, Genervon's research team reported new findings that its drug candidate GM6 attenuates Alzheimer's disease in an early AD transgenic APP mice model.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today its participation in a $2.4 million research grant awarded to the University of Pennsylvania under the "American Recovery and Reinvestment Act of 2009". The new grant will fund research over two years in the laboratories of Daniel Rader, M.D. of the University of Pennsylvania School of Medicine, Sekar Kathiresan, M.D. of Massachusetts General Hospital (MGH) and Harvard Medical School, and Alnylam.
A team of researchers describes the presence of PDCoV strains in plasma samples of three Haitian children with acute undifferentiated febrile illness.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sherry H Weitzen, MD 280 Chestnut St Fl 2, Springfield, MA 01199-1001 Ph: (413) 794-5700 | Sherry H Weitzen, MD 48 Sanderson St, Greenfield, MA 01301-2778 Ph: (413) 773-2778 |
News Archive
In response to a story examining 2011's top foreign policy issues, Serra Sippel, president of the Center for Health and Gender Equity, writes in a letter to the editor, published in The Hill, that "[g]lobal health was disturbingly absent from" the story. "Global health policy is at a critical turning point right now with the impending implementation of President Obama's Global Health Initiative, which will change our fundamental approach to health programs and policy," according to Sippel.
Following the closure of several research programs for Alzheimer's disease, in early 2018 the FDA issued a release entitled "Draft Guidance for Industry: Early Alzheimer's Disease: Developing Drugs for Treatment." Encouraged by the proposed changes in the new guidance, Genervon's research team reported new findings that its drug candidate GM6 attenuates Alzheimer's disease in an early AD transgenic APP mice model.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today its participation in a $2.4 million research grant awarded to the University of Pennsylvania under the "American Recovery and Reinvestment Act of 2009". The new grant will fund research over two years in the laboratories of Daniel Rader, M.D. of the University of Pennsylvania School of Medicine, Sekar Kathiresan, M.D. of Massachusetts General Hospital (MGH) and Harvard Medical School, and Alnylam.
A team of researchers describes the presence of PDCoV strains in plasma samples of three Haitian children with acute undifferentiated febrile illness.
› Verified 6 days ago
Franklin R Thomas, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 489 Bernardston Rd Ste 108, Greenfield, MA 01301 Phone: 413-325-8500 | |
Peter Brooks Koppenheffer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 48 Sanderson St, Greenfield, MA 01301 Phone: 413-773-2022 | |
Dr. Patricia A Iverson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 329 Conway St, Valley Medical Group, Pc-greenfield Health Center, Greenfield, MA 01301 Phone: 413-774-6301 Fax: 866-644-0871 | |
Dr. Sara A Rourke, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 48 Sanderson St, Greenfield, MA 01301 Phone: 413-773-2022 Fax: 413-773-4945 | |
Margit Lisa Walker, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 329 Conway St, Greenfield Health Center, Greenfield, MA 01301 Phone: 413-774-6301 Fax: 413-772-3314 | |
Dr. Jennifer Elizabeth Madden, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 48 Sanderson St, Greenfield, MA 01301 Phone: 413-773-2022 Fax: 413-773-4945 |